Melius MicroBiomics is a biotechnology company developing microbiome therapeutics built around genetically engineered microbial medicines. The company integrates microbiology and bioengineering to create live biotherapeutic programs aimed at restoring microbiome balance and improving gut health and related outcomes. Public materials also reference proprietary formulation technologies and continued progress toward clinical evaluation of engineered microbial therapies.